Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Risk versus benefit of lymph node dissection during prostatectomy

The lack of standardized nomenclature and level 1 evidence has led to controversy regarding pelvic lymph node dissection during radical prostatectomy. However, the knowledge of metastases presence and location can be valuable to guide therapy. Including internal iliac nodes in standard dissection can improve metastasis detection, with minimal added risk of complications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Yuh, B. E., Ruel, N. H., Mejia, R., Novara, G. & Wilson, T. G. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer. BJU Int. doi:10.1111/j.1464-410X.2012.11788.x.

  2. Kim, K. H. et al. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis. BJU Int. doi:10.1111/j.1464-410X.2012.11765.x.

  3. Briganti, A. et al. Pelvic lymph node dissection in prostate cancer. Eur. Urol. 55, 1251–1265 (2009).

    Article  Google Scholar 

  4. Katz, D. J. et al. Lymph node dissection during robotic-assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection. BJU Int. 106, 391–396 (2010).

    Article  Google Scholar 

  5. Liss, M. et al. Outcomes and Complications of Pelvic Lymph Node Dissection During Robotic-Assisted Radical Prostatectomy. World J. Urol. doi:10.1007/s00345-013-1056-9.

  6. Feicke, A. et al. Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. Eur. Urol. 55, 876–883 (2009).

    Article  Google Scholar 

  7. Silberstein, J. L., Derweesh, I. H. & Kane, C. J. Lymph node dissection during robot-assisted radical prostatectomy: where do we stand? Prostate Cancer Prostatic Dis. 12, 227–232 (2009).

    Article  CAS  Google Scholar 

  8. Clark, T. et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J. Urol. 169, 145–148 (2003).

    Article  Google Scholar 

  9. Cooperberg, M. R., Kane, C. J., Cowan, J. E. & Carroll, P. R. Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy. BJU Int. 105, 88–92 (2010).

    Article  Google Scholar 

  10. Bader, P., Burkhard, F. C., Markwalder, R. & Studer, U. E. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J. Urol. 168, 514–518 (2002).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher J. Kane.

Ethics declarations

Competing interests

C. J. Kane declares that he has acted as a consultant and received honoraria from Amgen, Dendreon, Intuitive Surgical and Janssen. M. A. Liss declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kane, C., Liss, M. Risk versus benefit of lymph node dissection during prostatectomy. Nat Rev Urol 10, 262–263 (2013). https://doi.org/10.1038/nrurol.2013.77

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2013.77

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer